ADDRESSING CLINICAL UNMET NEEDS IN WOMEN'S HEALTH
WE HAVE ENTERED A NEW ERA IN THE PRACTICE OF MEDICINE.
Molecular Diagnostics is currently being paved by novel assays based on next-generation sequencing (NGS)
and qPCR technologies. Through these methods, we can analyse the genome and understand
biological systems on the deepest possible level. This also means physicians and patients can now make
critical health care decisions using genomic information. Genetic analyses can now help physicians improve prenatal and reproductive care, detect conditions earlier and allay anxiety to women.
iGene Laboratory's offerings include iGene Non Invasive Prenatal Test (NIPT),
Fetal RhD Status and Carrier Gene
CLINICAL WHOLE-GENOME SEQUENCING TESTS AT iGENE LABORATORY IS AVAILABLE TO:
Screen and conduct risk assessment for certain genetic diseases.
Deliver reports on questions about genetic variations and rare diseases.
Help physicians provide genetically informed decisions for their patient.
Established in 2014, iGene Laboratory is a wholly owned subsidiary of INEX INNOVATE. We focus on delivering testing services. The lab, whilst located in Singapore, serves medical professionals and patients region-wide. The Laboratory offers tests novel encompassing novel technology platforms such as next generation sequencing, liquid biopsy, digital pathology and bioinformatics.
WE DEVELOP PROPRIETARY TECHNOLOGY AND COLLABORATE WITH GLOBAL INSTITUTES OF MEDICAL EXCELLENCE
IGENE LAB is amongst the first private Next Generation Sequencing Laboratories (NGS) in Singapore licensed by the Ministry Of Health, and the first clinical lab in Singapore that is College of American Pathologist (CAP) Accredited for Non Invasive Prenatal Tests (NIPT).